Denosumab administration for bone metastases from solid tumors: a retrospective cross-sectional study

BACKGROUND: Little is known on how denosumab reduces skeletal-related events (SREs) by bone metastases from solid tumors. We sought to evaluate the effect of denosumab administration in patients with bone metastases from solid tumors. METHODS: Data of patients treated with denosumab were collected f...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizuta, Kohei, Oshiro, Hiromichi, Katsuki, Ryo, Tsuha, Yuichi, Aoki, Yusuke, Tome, Yasunori, Nishida, Kotaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585877/
https://www.ncbi.nlm.nih.gov/pubmed/37853409
http://dx.doi.org/10.1186/s12885-023-11495-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585877/
https://www.ncbi.nlm.nih.gov/pubmed/37853409
http://dx.doi.org/10.1186/s12885-023-11495-w

Ejemplares similares